NHS

Keytruda, NHS, NICE, Microsatellite instability, Mismatch repair deficient (dMMR) mutations

Keytruda Gets Green Light from NHS for New Cancer ‘Basket’

Anika Sharma

MSD’s Keytruda (pembrolizumab) has secured a significant recommendation from the UK’s National Institute for Health and Care Excellence (NICE), signaling ...

NHS may increase the cost of new antibiotic subscriptions

NHS may increase the cost of new antibiotic subscriptions

SG Tylor

Proposals are underway to double the yearly subscription payments made by NHS England to developers of innovative antibiotics from £10 ...

Future NHS Award goes to an AI-based tool for heart disease

Future NHS Award goes to an AI-based tool for heart disease

SG Tylor

A digital tool created by NHS researchers to expedite the diagnosis of heart disease has been honored with the Future ...

BMS' Sotyktu is approved for psoriasis usage by the NHS | Pharmtales

BMS’ Sotyktu is approved for psoriasis usage by the NHS

SG Tylor

Source: Bristol-Myers Squibb Just weeks after receiving approval in the UK, Bristol-Myers Squibb’s novel oral therapy for psoriasis, SotyKtu, has ...